While DCs are thought to present tumor‐associated antigens to naive T cells and contribute to an anti‐tumor role, our findings indicated that high levels of activated DCs within the tumor were inversely correlated with densities of CD8 T cells, and predicted worse outcome for patients with EC. Here, CD8A is linked to neoplasm.